Acella Pharmaceuticals, LLC recalls NAPROXEN ORAL SUSPENSION
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Chemical contamination; presence of lead and lithium above specification
- Products
-
- NAPROXEN ORAL SUSPENSION
- Company
- Acella Pharmaceuticals, LLC
- Where it was sold
-
Nationwide
Nationwide
- Units affected
- 6,336 bottles
- About this recall
- NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, Made in Canada NDC 42192-619-16